Zhou, Qing <br/><br/>
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer.  [electronic resource] 

 -  Investigational new drugs  Apr 2011 
 - 340-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-009-9383-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Methoxyestradiol<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Demography<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Estradiol--administration & dosage<br/>Estrenes--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--blood<br/>Rats<br/>Species Specificity